Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-23

Clinical Trial Update: A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the PIKA Rabies Vaccine (Vero Cell) for human use to prevent rabies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIKA Rabies Vaccine (Vero Cell) – Freeze-dried (PIKA rabies vaccine)

Snippet

Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd. | Conditions: Rabies, Prevention | Phase 3 | Status: UNKNOWN